Navigation Links
ULURU Inc. Announces Senior Management Change
Date:3/9/2009

- PRESIDENT AND CEO RESIGNS -

ADDISON, Texas, March 9 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced the resignation of Kerry P. Gray as Chief Executive Officer of the Company effective immediately. Following his resignation as Chief Executive Officer, Mr. Gray will continue to serve as a Director of the Company.

Renaat Van den Hooff has been appointed by the Board of Directors to assume the position of President and Chief Executive Officer. Mr. Van de Hooff was previously the Company's Executive Vice President of Operations.

William W. Crouse, Chairman of the Board of Directors, stated, "We thank Kerry for his significant contributions to the Company and look forward to his continued involvement as a Director of the Company."

"I believe that Uluru is well positioned to establish a significant global wound care franchise. The Company has a highly innovative technology from which an exciting range of wound care products are being developed, which will contribute to improving patient outcomes. I am very pleased with what has been achieved since the launch of the Company in October 2005," commented Mr. Gray.

About ULURU Inc.:

ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Nanoflex(TM) Aggregate technology. For further information about ULURU Inc., please visit our website at www.uluruinc.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating to future financial performance of ULURU Inc. (the "Company") and the impact of leadership changes on our operations. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2007 and quarterly report on Form 10-Q for the quarter ended September 30, 2008, and other reports filed by us with the Securities and Exchange Commission.

    Contact: Company
    Renaat Van den Hooff
    President & CEO
    Terry K. Wallberg
    Vice President & CFO
    (214) 905-5145


'/>"/>
SOURCE ULURU Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2008 and to Provide a Business Update
2. ULURU Inc. Announces the Launch of the Altrazeal(TM) Website
3. ULURU Inc. Hosts Symposium on Altrazeal(TM) at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
4. ULURU Inc. Announces Poster Presentations at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
5. ULURU Inc. to Present at the Thomas Weisel Partners Healthcare Conference 2008
6. ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors
7. ULURU Inc. Reports First Quarter 2008 Financial Results
8. ULURU Inc. Announces the Launch Plan for Altrazeal(TM)
9. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter Ended December 31, 2007 and Provide a Business Update
10. ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update
11. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well ... VW+ 002. The drinks have been produced in collaboration with Zlatan Ibrahimovic and ... your workout. , After a successful launch in Sweden last year, the next ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest tale ... each of his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, ... City, and impassioned writer. , When asked of her new book, Marjorie says, “‘The ...
(Date:1/20/2017)... ... ... Forgive You”: a fine examination of how God handles sin, including how to let ... Stephen Miller, who, for over ten long years has been waiting to release this powerful ... Tobago, he has been serving the Lord for over twenty years, and he has been ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Christmas in Suffolk”: a story of ... Seymour, who lives in Lafayette, Indiana where she works in a daycare and looks ... writes. , Published by Christian Faith Publishing, Sara Seymour’s new book is an adventure ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Knowledge is God’s Lighthouse”: a moving ... is God’s Lighthouse” is the creation of published author, Gene Gaapf, a retired truck ... , “I have been writing since high school and have many different titles,” ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... January 19, 2017 The global  pacemaker market  is expected ... Grand View Research, Inc. The heightening prevalence of cardiac conditions coupled with the ... Pacemaker globally. In addition, technological enhancements in these devices are supporting the expansion ... ... Grand View Research Logo ...
(Date:1/19/2017)...   Synthetic Biologics, Inc. (NYSE MKT: ... to preserve the microbiome to protect and restore ... initiate a Phase 2b/3 adaptive pivotal trial for ... designed to reduce methane production by certain microorganisms ... treat the underlying cause of irritable bowel syndrome ...
(Date:1/18/2017)... DALLAS , Jan. 18, 2017  Aprima ... health records (EHR), practice management (PM) and revenue ... announced the acquisition of a former reseller Healthcare ... part of the agreement, Aprima will assume full ... providers in 125 medical practices across 15 states. ...
Breaking Medicine Technology: